XML 79 R5.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Millions
Total
Total Hippo Stockholders' Equity
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Non controlling Interests
Beginning balance (in shares) at Dec. 31, 2023     24,148,308        
Beginning balance at Dec. 31, 2023 $ 384.7 $ 377.9 $ 0.0 $ 1,615.2 $ (2.9) $ (1,234.4) $ 6.8
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (33.1) (35.7)       (35.7) 2.6
Other comprehensive income (loss) (0.5) (0.5)     (0.5)    
Issuance of common stock from stock plans and contingently issuable shares (in shares)     261,416        
Issuance of common stock from stock plans and contingently issuable shares 1.2 1.2   1.2      
Shares withheld related to net share settlement (1.2) (1.2)   (1.2)      
Stock-based compensation expense 9.5 9.5   9.5      
Other (5.8)           (5.8)
Ending balance (in shares) at Mar. 31, 2024     24,409,724        
Ending balance at Mar. 31, 2024 $ 354.8 351.2 $ 0.0 1,624.7 (3.4) (1,270.1) 3.6
Beginning balance (in shares) at Dec. 31, 2024 24,866,803   24,866,803        
Beginning balance at Dec. 31, 2024 $ 365.2 362.1 $ 0.0 1,639.7 (2.7) (1,274.9) 3.1
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (45.4) (47.7)       (47.7) 2.3
Other comprehensive income (loss) $ 2.1 2.1     2.1    
Issuance of common stock from stock plans and contingently issuable shares (in shares) 75,496   290,411        
Issuance of common stock from stock plans and contingently issuable shares $ 1.0 1.0   1.0      
Shares withheld related to net share settlement (3.2) (3.2)   (3.2)      
Stock-based compensation expense 8.5 8.5   8.5      
Distributions to noncontrolling interests $ (2.5)           (2.5)
Ending balance (in shares) at Mar. 31, 2025 25,157,214   25,157,214        
Ending balance at Mar. 31, 2025 $ 325.7 $ 322.8 $ 0.0 $ 1,646.0 $ (0.6) $ (1,322.6) $ 2.9